értekezés - Semmelweis Egyetem Doktori Iskola
értekezés - Semmelweis Egyetem Doktori Iskola értekezés - Semmelweis Egyetem Doktori Iskola
children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 2006; 27: 73-7. 165. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009; 30: 3-8. 166. Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003; 108: 2368-76. 167. Nasser N, Perles Z, Rein AJ, Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 2006; 27: 87-90. 168. Fried I, Bar-Oz B, Perles Z, Rein AJ, Zonis Z, Nir A. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J Pediatr 2006; 149: 28-31. 169. Fried I, Bar-Oz B, Algur N, Fried E, Gavri S, Yatsiv I, Perles Z, Rein AJ, Zonis Z, Bass R, Nir A. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 2006; 118: e1165-e1168. 170. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004; 25: 341-6. 171. Cohen S, Springer C, Avital A, Perles Z, Rein AJ, Argaman Z, Nir A. Amino- terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics 2005; 115: 1347-50. 172. Hayakawa H, Komada Y, Hirayama M, Hori H, Ito M, Sakurai M. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol 2001; 37: 4-9. 173. Kádár K, Nagy E, Gál K, Oprea V, Hartyánszky I, Gyarmati G, Tóth A, Sikos Z. B-natriuretikus peptid meghatározás jelentősége gyermekkori szívbetegségekben. Orv Hetil 2007; 148: 265-70. 104
174. Matsuoka S, Kurahashi Y, Tomimatsu H, Miyao M, Yamazaki Y, Nishiuchi T, Saito S. Plasma atrial natriuretic peptide levels in patients with ventricular septal defect. J Pediatr 1987; 110: 578-80. 175. Kikuchi K, Nishioka K, Ueda T, Shiomi M, Takahashi Y, Sugawara A, Nakao K, Imura H, Mori C, Mikawa H. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases. J Pediatr 1987; 111: 335-42. 176. Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003; 45: 249-54. 177. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003; 57: 191-7. 178. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002; 103: 75-7. 179. Muta H, Ishii M, Maeno Y, Akagi T, Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91: 649-52. 180. Dodge-Khatami A, Buchel EV, Knirsch W, Kadner A, Rousson V, Dave HH, Bauersfeld U, Pretre R. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 2006; 82: 983-8. 181. Tulevski II, Groenink M, van Der Wall EE, van Veldhuisen DJ, Boomsma F, Stoker J, Hirsch A, Lemkes JS, Mulder BJ. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27-30. 182. Westerlind A, Wåhlander H, Berggren H, Lundberg PA, Holmgren D. Plasma levels of natriuretic peptide type B and A in children with heart disease with different types of cardiac load or systolic dysfunction. Clin Physiol Funct Imaging 2008; 28: 277-84. 105
- Page 53 and 54: ln NT-proXNP (pmol/l) 10,0 8,0 6,0
- Page 55 and 56: 4.6. A hemodinamikai paraméterek j
- Page 57 and 58: A műtét után egy nappal az SVI
- Page 59 and 60: 4.6.5. A hemodinamikai paraméterek
- Page 61 and 62: delta CI (l/min/m2) 8.0 4.0 0.0 -4.
- Page 63 and 64: 4.7.2. A klinikai paraméterek öss
- Page 65 and 66: 4.9. A nátriuretikus peptidek diag
- Page 67 and 68: 5. Megbeszélés Egy 10 év adatait
- Page 69 and 70: verőtérfogat műtét utáni vált
- Page 71 and 72: lélegeztetve. A felnőttekben elfo
- Page 73 and 74: mediátorok felszabadulását okozz
- Page 75 and 76: mind az NT-proBNP molekulából tar
- Page 77 and 78: 5.4. A nátriuretikus peptidek és
- Page 79 and 80: magasabb NT-proANP szintek és a na
- Page 81 and 82: emelkedése megelőzi a vesefunkci
- Page 83 and 84: kockázatokkal járhat a betegekre
- Page 85 and 86: 5. A szívindex referencia értéke
- Page 87 and 88: Summary Natriuretic peptide levels
- Page 89 and 90: 12. Sudoh T, Minamino N, Kangawa K,
- Page 91 and 92: 33. Murakami Y, Shimada T, Inoue S,
- Page 93 and 94: 54. Lang RE, Thölken H, Ganten D,
- Page 95 and 96: 75. Fukuda Y, Hirata Y, Taketani S,
- Page 97 and 98: 95. Yoshimoto T, Naruse M, Tanabe A
- Page 99 and 100: 116. Tei M, Horie M, Makita T, Suzu
- Page 101 and 102: esponses to brain natriuretic pepti
- Page 103: paracrine factor in cultured cardia
- Page 107 and 108: 191. Lan YT, Chang RK, Alejos JC, B
- Page 109 and 110: 213. Egan JR, Festa M, Cole AD, Nun
- Page 111 and 112: 234. Lehot JJ, Villard J, Piriz H,
- Page 113 and 114: 4. Székely A, Sápi E, Breuer T, K
174. Matsuoka S, Kurahashi Y, Tomimatsu H, Miyao M, Yamazaki Y, Nishiuchi T,<br />
Saito S. Plasma atrial natriuretic peptide levels in patients with ventricular septal<br />
defect. J Pediatr 1987; 110: 578-80.<br />
175. Kikuchi K, Nishioka K, Ueda T, Shiomi M, Takahashi Y, Sugawara A, Nakao<br />
K, Imura H, Mori C, Mikawa H. Relationship between plasma atrial natriuretic<br />
polypeptide concentration and hemodynamic measurements in children with<br />
congenital heart diseases. J Pediatr 1987; 111: 335-42.<br />
176. Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma<br />
natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003;<br />
45: 249-54.<br />
177. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M. Plasma<br />
brain natriuretic peptide and the evaluation of volume overload in infants and<br />
children with congenital heart disease. Acta Med Okayama 2003; 57: 191-7.<br />
178. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic<br />
peptide as a predictor of haemodynamically significant patent ductus arteriosus<br />
in preterm infants. Clin Sci (Lond) 2002; 103: 75-7.<br />
179. Muta H, Ishii M, Maeno Y, Akagi T, Kato H. Quantitative evaluation of the<br />
changes in plasma concentrations of cardiac natriuretic peptide before and after<br />
transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91: 649-52.<br />
180. Dodge-Khatami A, Buchel EV, Knirsch W, Kadner A, Rousson V, Dave HH,<br />
Bauersfeld U, Pretre R. Brain natriuretic peptide and magnetic resonance<br />
imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 2006;<br />
82: 983-8.<br />
181. Tulevski II, Groenink M, van Der Wall EE, van Veldhuisen DJ, Boomsma F,<br />
Stoker J, Hirsch A, Lemkes JS, Mulder BJ. Increased brain and atrial natriuretic<br />
peptides in patients with chronic right ventricular pressure overload: correlation<br />
between plasma neurohormones and right ventricular dysfunction. Heart 2001;<br />
86: 27-30.<br />
182. Westerlind A, Wåhlander H, Berggren H, Lundberg PA, Holmgren D. Plasma<br />
levels of natriuretic peptide type B and A in children with heart disease with<br />
different types of cardiac load or systolic dysfunction. Clin Physiol Funct<br />
Imaging 2008; 28: 277-84.<br />
105
Change language